Atelvia and Fever - a phase IV clinical study of FDA data

Summary:

Fever is reported as a side effect among people who take Atelvia (risedronate sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Vitamin D, and have Osteopenia.

The phase IV clinical study analyzes which people have Fever when taking Atelvia. It is created by eHealthMe based on reports of 587 people who have side effects when taking Atelvia from the FDA, and is updated regularly.

What is Atelvia?

Atelvia has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 611 Atelvia users. Check the latest studies of Atelvia.

What is Fever?

Fever is found to be associated with 3,494 drugs and 6,195 conditions by eHealthMe. Check the latest studies of Fever.

On Jul, 05, 2026

587 people reported to have side effects when taking Atelvia.
Among them, 23 people (3.92%) have Fever.

Among these 23 people:

How long have people been on Atelvia when they have Fever? *

What is the gender of people who have Fever when taking Atelvia? *

female: 100 %
male: 0.0 %

What is the age of people who have Fever when taking Atelvia? *

What are other drugs people take besides Atelvia? *

What are other side effects people have besides Fever? *

Influenza Like Illness: 10 people, 43.48%
Headache (pain in head): 9 people, 39.13%
Joint Pain: 7 people, 30.43%
Diarrhea: 6 people, 26.09%
Chills (felling of cold): 6 people, 26.09%
Chest Pain: 5 people, 21.74%
Muscle Twitching: 5 people, 21.74%
Back Pain: 5 people, 21.74%
Dyspnea (difficult or laboured breathing): 4 people, 17.39%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 17.39%

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 17.39%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.04%
High Blood Pressure: 2 people, 8.70%
Brain Neoplasm Benign (non-cancerous tumour of brain): 2 people, 8.70%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 8.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.35%
Bone Density Abnormal: 1 person, 4.35%
Bone Disorder: 1 person, 4.35%
Bone Loss: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Atelvia and have Fever?

- Check whether Fever is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atelvia:

Atelvia (611 reports)

Fever treatments and more:

Fever (498,666 reports)

Browse all side effects of Atelvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fever:

Fever (3,494 drugs)

Browse all the conditions that are associated with Fever:

Fever (6,195 conditions)

Related publications that referenced our studies

Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Atelvia) and Atelvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.